Animal models of Alzheimer's disease: Therapeutic implications

Journal of Alzheimer's Disease

Volumn 15, Issue 4, 2008, Pages 507-521

  Woodruff Pak, Diana S ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Dog; Fruit fly; Hypercholesterolemic rabbit; Non human primate; Rat; Transgenic mouse

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

AGING; ALZHEIMER DISEASE; BEHAVIOR; CHOLESTEROL DIET; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DOG; DROSOPHILA MELANOGASTER; GENETIC ASSOCIATION; GENETIC RISK; GESTATION PERIOD; HUMAN; HYPERCHOLESTEROLEMIA; LEARNING; LIFE EXPECTANCY; LIFESPAN; MEMORY; MOLECULAR GENETICS; NEUROANATOMY; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMATE; PRIORITY JOURNAL; PROGENY; RABBIT; REPRODUCIBILITY; REVIEW; RODENT; SENESCENCE ACCELERATED MOUSE; TAUOPATHY; TRANSGENIC MOUSE; VALIDITY;

EID: 58149380025     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-15401     Document Type: Review

References (65)

1. M.D. Adams, S.E. Celniker, R.A. Holt, C.A. Evans, J.D. Gocayne, P.G. Amanatides, S.E. Scherer, P.W. Li, R.A. Hoskins, R.F. Galle et al., The genome sequence of Drosophila melanogaster, Science 287 (2000), 2185-2195.
2. G.W. Arendash, D.L. King, M.N. Gordon, D. Morgan, J.M. Hatcher, C.E. Hope and D.M. Diamond, Progressive, agerelated behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes, Brain Res 891 (2001), 42-53.
3. A.N. Begum, F. Yang, E. Teng, S. Hu, M.R. Jones, E.R. Rosario, W. Beech, B. Hudspeth, G.M. Cole and S.A. Frautschy, Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic loss in an Aβ-infusion Alzheimer's disease (AD) model, J Alzheimers Dis 15 (2008), 625-640.
4. N. Bons, N. Mestre and A. Petter, Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus mirinus. Neurobiol Aging 13 (1991), 99-105.
5. N. Bons, F. Rieger, D. Prudhomme, A. Fisher and K.-H. Krause, Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease? Genes, Brain, Behav 5 (2006), 120-130.
6. A.V. Braunmuhl, Kongophile angiopathie und senile plaques bei greisen hunden, Arch Psychiatr Nervenkr 194 (1956), 395-414.
7. J.J. Buccafusco, Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders, J Alzheimers Dis 15 (2008), 709-720.
8. R. Coico and D.S. Woodruff-Pak, Immunotherapy for Alzheimer's disease: harnessing our knowledge of T cell biology using a cholesterol-fed rabbit model, J Alzheimers Dis 15 (2008), 657-671.
9. C.A. Colton, D.M. Wilcock, D.A. Wink, J. Davis, W.E. Van Nostrand and M.P. Vitek, The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP, J Alzheimers Dis 15 (2008), 571-587.
10. L.C. Cork, R.E. Powers, D.J. Selkoe, P. Davies, J.J. Geyer and D.L. Price, Neurofibrillary tangles and senile plaques in aged bears, J Neuropathol Exp Neurol 47 (1988), 629-641.
11. C.W. Cotman and E. Head, The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches, J Alzheimers Dis 15 (2008), 685-707.
12. B.J. Cummings, E. Head, W. Ruehl, N.W. Milgram and C.W. Cotman, The canine as an animal model of human aging and dementia, Neurobiol Aging 17 (1996), 259-268.
13. M. Driscoll and B. Gerstbrein, Dying for a cause: invertebrate genetics takes on human neurodegeneration, Nat Rev Genet 4 (2003), 181-194.
14. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-Tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M.N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy and S. Younkin, Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1, Nature 383 (1996), 710-713.
15. S.A. Farr, W.A. Banks, K. Uezu, A. Sano, F.S. Gaskin and J.E. Morley, Antibody to beta-amyloid protein increases acetylcholine in the hippocampus of 12 month SAMP8 male mice, Life Sci 73 (2003), 555-562.
16. M.R. Foy, M. Baudry, R.D. Brinton and R.F. Thompson, Estrogen and hippocampal plasticity in rodent models, J Alzheimers Dis 15 (2008), 589-603.
17. S.A. Frautschy, A. Baird and G.M. Cole, Effects of injected Alzheimer beta-amyloid cores in rat brain, Proc Natl Acad Sci USA 88 (1991), 8362-8366.
18. S.A. Frautschy, F. Yang, L. Calderon and G.M. Cole, Rodent models of Alzheimer's disease: rat Abeta infusion approaches to amyloid deposits, Neurobiol Aging 17 (1996), 311-321.
19. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, F. Gillespie et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, Nature 373 (1995), 523-527.
20. O. Ghribi, B. Larsen, M. Schrag and M.M. Herman, High cholesterol content in neurons increases BACE, β-amyloid, phosphorylated tau levels in rabbit hippocampus, Exp Neurol 200 (2006), 460-467.
21. O. Ghribi, Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle, J Alzheimers Dis 15 (2008), 673-684.
22. G. Giaccone, L. Verga, M. Finazzi, B. Pollo, F. Tagliavini, B. Frangione and O. Bugiani. Cerebral preamyloid deposits and congophilic angiopathy in aged dogs, Neurosci Lett 114 (1990), 178-183.
23. M.N. Gordon, D.L. King, D.M. Diamond, P.T. Jantzen, K.V. Boyett, C.E. Hope, J.M. Hatcher, G. DiCarlo, W.P. Gottschall, D. Morgan and G.W. Arendash, Correlation between cognitive deficits and Abeta deposits in transgenic APP + PS1 mice, Neurobiol Aging 22 (2001), 377-385.
24. J. Gotz and L.M. Ittner, Animal models of Alzheimer's disease and frontotemporal dementia, Nature Rev Neurosci 9 (2008), 532-544.
25. D. Graur, L. Duret and M. Gouy, M. Phylogenetic position of the order Lagomorpha (rabbits, hares and allies), Nature 379 (1996), 333-335.
26. W.J. Hadlow, Criteria for development of animal models of diseases of the nervous system, Am J Pathol 101(Suppl 3) (1980), S213-219.
27. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao and K. Duff, Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes, Nat Med 4 (1998), 97-100.
28. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang and G. Cole, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science 274 (1996), 99-102.
29. K. Iijima and K. Iijima-Ando, Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-β 42, J Alzheimers Dis 15 (2008), 523-540.
30. A. Ivantcheva, S. Didier, E. Keller, C Guedot and N. Bons, Toward an association between cognitive functions and social behavior exhibited during normal and pathological aging by Microcebus murinus, Neurobiol Aging 19(Suppl 4) (1998), S286.
31. E.M. Johnstone, M.O. Chaney, F.H. Norris, R. Pascual and S.P. Little, Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis, Brain Res Mol Brain Res 10 (1991), 299-305.
32. V. Khurana, Modeling taupathology in the fruit fly Drosophila melanogaster, J Alzheimers Dis 15 (2008), 541-553.
33. B.C. Kraemer, B. Zhang, J.B. Leverenz, J.H. Thomas, J.Q. Trojanowski and G.D. Schellenberg, Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy, Proc Natl Acad Sci USA 100 (2003), 9980-9985.
34. R.W. Manning, C.M. Reid, R.A. Lampe and L.G. Davis, Identification in rodents and other species of an mRNA homologous to the human beta-amyloid precursor, Brain Res 427 (1988), 293-297.
35. J.E. Morley, S.A. Farr, V.B. Kumar and W.A. Banks, Alzheimer's disease through the eye of a mouse. Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize, Peptide 23 (2002), 589-599.
36. A.B. Moore, M.W. Bondi, D.P. Salmon and C. Murphy, Eyeblink classical conditioning to auditory and olfactory stimuli: performance among older adults with and without the apolipoprotein E epsilon 4 allele, Neuropsychology 19 (2005), 437-445.
37. D. Morgan and R.K. Keller, What evidence would prove the amyloid hypothesis? Toward rational drug treatments for Alzheimer's disease, J Alzheimers Dis 4 (2002), 257-260.
38. D. Morgan, S. Munireddy, J. Alamed, J. DeLeon, D.M. Diamond, P. Bickford, M. Hutton, J. Lewis, E. McGowan and M. Gordon, Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice, J Alzheimers Dis 15 (2008), 605-614.
39. H. Nabeshi, S. Oikawa, S. Inoue, K. Nishino and S. Kawanishi, Proteomic analysis for protein carbonyl as an indicator of oxidative damage in senescence-accelerated mice, Free Radic Res 40 (2006), 1173-1181.
40. P.T. Nelson, S.G. Greenberg and C.B. Saper, Neurofibrillary tangles in the cerebral cortex of sheep, Neurosci Lett 170 (1994), 187-190.
41. C. Nusslein-Volhard and E. Wieschaus, Mutations affecting segment number and polarity in Drosophila, Nature 287 (1980), 795-801.
42. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari and F.M. LaFerla, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron 39 (2003), 409-421.
43. M. Pallas, A. Camins, M.A. Smith, G. Perry, H.G. Lee and G. Casadesus, From Aging to Alzheimer's Disease: Unveiling "The Switch" with the Senescence-Accelerated Mouse Model (SAMP8), J Alzheimers Dis 15 (2008), 615-624.
44. M.B. Podlisny, D.R. Tolan and D.J. Selkoe, Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease, Am J Pathol 138 (1991), 1423-1435.
45. R. Radde, C. Duma, M. Goedert and M. Jucker, The value of incomplete mouse models of Alzheimer's disease, Eur J Nucl Med Mol Imaging 35(Suppl 1) (2008), S70-74.
46. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games and P. Seubert, Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature 400 (1999), 173-177.
47. C. Schultz, E. Ghebremedhin, I. Sassin, E. Braak and H. Braak, Abnormally phosphorylated tau protein in neurons and glial cells of aged baboons. In Alzheimer's disease and related disorders, K. Iqbal, D.F. Schwaabm B. Winblad and H.M. Wisniewski, eds, John Wiley and Sons, West Sussex, England, 1999, pp. 179-185.
48. D.J. Selkoe, D.S. Bell, M.B. Podlisny, D.L. Price and L.C. Cork, Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease, Science 235 (1987), 873-877.
49. D.L. Sparks, S.W. Scheff, J.C. Hunsaker III, H. Liu, T. Landers and D.R. Gross, Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol, Exp Neurol 126 (1994), 88-94.
50. D.L. Sparks, J. Lochhead, D. Horstman, T. Wagoner and T. Martin, Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer Amyloid β (Aβ) in rabbit brain, J Alzheimers Dis 4 (2002), 523-529.
51. D.L. Sparks and B.G. Schreurs, Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc Natl Acad Sci USA 100 (2003), 11065-11069.
52. D.L. Sparks, Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid β in rabbit brain, J Mol Neurosci 24 (2004), 97-104.
53. D.L. Sparks, R. Friedland, S. Petanceska, B.G. Schreurs, J. Shi, G. Perry, M.A. Smith, A. Sharma, S. Derosa, C. Ziolkowski and G. Stankovic, Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology, J Nutr Health Aging 10 (2006), 247-254.
54. D.L. Sparks, The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: the old, the new and the pilot, J Alzheimers Dis 15 (2008), 641-656.
55. A. Takashima, T. Honda, K. Yasutake, G. Michel, O. Murayama, M. Murayama, K. Ishiguro and H. Yamaguchi, Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons, Neurosci Res 31 (1998), 317-323.
56. T.L. Tekirian, G.M. Cole, M.J. Russell, F. Yang, D.R. Wekstein, E. Patel, D.A. Snowdon, W.R. Markesbery and J.W. Geddes, Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains, Neurobiol Aging 17 (1996), 249-257.
57. F.S. Vogel, Needs for animal models of human diseases of the nervous system, Am J Pathol 101(Suppl 3) (1980), S201-211.
58. H.M. Wisniewski, A.B. Johnson, C.S. Raine, W.J. Kay and R.D. Terry, Senile plaques and cerebral amyloidosis in aged dogs: A histochemical and ultrastructural study, Lab Invest 23 (1970), 287-296.
59. H.M. Wisniewski, B. Ghetti and R.D. Terry, Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys, J Neuropathol Exp Neurol 32 (1973), 566-584.
60. D.S. Woodruff-Pak and M. Papka, Huntington's disease and eyeblink classical conditioning: Normal learning but abnormal timing, J Int Neuropsychol Soc 2 (1996), 323-334.
61. D.S. Woodruff-Pak and J.Q. Trojanowski, The older rabbit as an animal model: implications for Alzheimer's disease, Neurobiol Aging 17 (1996), 283-290.
62. D.S. Woodruff-Pak and M.E. Jaeger, Predictors of eyeblink classical conditioning over the adult age span, Psychol Aging 13 (1998), 193-205.
63. D.S. Woodruff-Pak and J.E. Steinmetz, eds, Eyeblink classical conditioning: Volume II: Animal models, Kluwer Academic Publishers, Boston, 2000.
64. D.S.Woodruff-Pak, A. Agelan and L. Del Valle, A rabbit model of AD: Valid at neuropathological, cognitive, and therapeutic levels, J Alzheimers Dis 11 (2007), 371-383.
65. D.M. Wilcock and C.A. Colton, Anti-Aβ immunotherapy in transgenic mice modeling Alzheimer's disease, J Alzheimers Dis 15 (2008), 555-569.